Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 4/20 | 0.36 |
| ▸ | CTSS | P25774 | 3/20 | 0.32 |
| ▸ | CTSK | P43235 | 3/20 | 0.32 |
| ▸ | CTSL | P07711 | 1/20 | 0.31 |
| ▸ | CTSB | P07858 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23200231 | 0.95 | MEN1 (0.43) | MEN1KMT2ACNR2CTSSCTSK | |
| SCHEMBL17694457 | 0.84 | MEN1 (0.42) | MEN1KMT2ACNR2TSHR | |
| SCHEMBL23200294 | 0.81 | ALDH3A1 (0.35) | — | |
| SCHEMBL17694505 | 0.81 | MEN1 (0.40) | MEN1KMT2ACNR2TSHR | |
| SCHEMBL28683256 | 0.81 | MEN1 (0.36) | MEN1KMT2ACNR2CTSSCTSK | |
| SCHEMBL23200206 | 0.80 | MEN1 (0.44) | MEN1KMT2ACNR2CTSSCTSK | |
| SCHEMBL10033529 | 0.79 | MEN1 (0.42) | MEN1KMT2ACNR2TSHR | |
| SCHEMBL23200650 | 0.79 | — | — | |
| SCHEMBL18722879 | 0.79 | NAAA (0.50) | TSHR | |
| SCHEMBL3735208 | 0.79 | CYP4F2 (0.43) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10882838-B2 | Cannabinergic compounds and uses thereof | NORTHEASTERN UNIVERSITY (US) | 2021-01-05 | — | — | US | disclosed |
| US-20190185443-A1 | Novel Cannabinergic Compounds And Uses Thereof | NORTHEASTERN UNIVERSITY | 2019-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190185443-A1 | Novel Cannabinergic Compounds And Uses Thereof | CNR2, CNR1, GPR18 | MEN1 3692/4885KMT2A 4458/4885CNR2 1/4885 |
| US-10882838-B2 | Cannabinergic compounds and uses thereof | CNR2, CNR1, GPR18 | MEN1 3570/4885KMT2A 4425/4885CNR2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.